Skip to main content
. 2017 Jan 28;23:513–520. doi: 10.12659/MSM.898688

Table 2.

Bio-marker expression between primary lesions and metastatic lymph nodes in patients with different subtypes of lung cancer.

Small-cell (n=5) Large-cell (n=4) Squamous-cell (n=24) Adenocarcinoma (n=15) P value
MDR-1 1 (25%) 1 (25%) 6 (25%) 3 (20%) 1.000
LRP 1 (20%) 3 (75%) 9 (37%) 5 (33%) 0.449
RRM-1 3 (60%) 1 (25%) 7 (29%) 9 (60%) 0.190
EGFR 2 (40%) 1 (25%) 10 (42%) 7 (47%) 0.965
ERCC-1 0 (0.0%) 2 (50%) 8 (33%) 6 (40%) 0.345
BRCA-1 2 (40%) 2 (50%) 3 (13%) 7 (47%) 0.051